Invivyd, Inc. – NASDAQ:IVVD
Invivyd stock price today
$0.57
+0.06
+11.82%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 2 hours
Invivyd stock price monthly change
-57.14%
month
Invivyd stock price quarterly change
-57.14%
quarter
Invivyd stock price yearly change
-87.41%
year
Invivyd key metrics
Market Cap | 52.40M |
Enterprise value | 42.11M |
P/E | -0.49 |
EV/Sales | N/A |
EV/EBITDA | -0.10 |
Price/Sales | N/A |
Price/Book | 0.36 |
PEG ratio | N/A |
EPS | -1.87 |
Revenue | N/A |
EBITDA | -219.03M |
Income | -206.81M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInvivyd stock price history
Invivyd stock forecast
Invivyd financial statements
| Jun 2023 | 0 | -50.22M | |
|---|---|---|---|
| Sep 2023 | 0 | -39.44M | |
| Dec 2023 | 3.02M | -73.65M | -2435.65% |
| Mar 2024 | 0 | -43.49M |
| Mar 2024 | 0 | -43.49M | |
|---|---|---|---|
| Sep 2025 | 86M | -19.77M | -22.99% |
| Oct 2025 | 86M | 4.04M | 4.71% |
| Dec 2025 | 143.75M | 17.34M | 12.06% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-09 | -0.54 | -0.36 |
|---|---|---|
| 2024-03-28 | -0.41 | -0.67 |
| 2024-05-09 | -0.51 | -0.38 |
| Jun 2023 | 315414000 | 33.85M | 10.73% |
|---|---|---|---|
| Sep 2023 | 274917000 | 28.41M | 10.34% |
| Dec 2023 | 229181000 | 51.71M | 22.56% |
| Mar 2024 | 215468000 | 36.97M | 17.16% |
| Jun 2023 | -37.39M | 32.59M | 270K |
|---|---|---|---|
| Sep 2023 | -35.35M | 95.13M | 92K |
| Dec 2023 | -59.24M | 77.91M | 141K |
| Mar 2024 | -50.21M | -140K | 39.10M |
Invivyd alternative data
| Aug 2023 | 84 |
|---|---|
| Sep 2023 | 84 |
| Oct 2023 | 84 |
| Nov 2023 | 84 |
| Dec 2023 | 84 |
| Jan 2024 | 84 |
| Feb 2024 | 84 |
| Mar 2024 | 84 |
| Apr 2024 | 84 |
| May 2024 | 94 |
| Jun 2024 | 94 |
| Jul 2024 | 94 |
Invivyd other data
31.51%
-23.63%
of IVVD is owned by hedge funds
37
-44
34.11M
-25.67M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 5000000 |
| May 2024 | 0 | 112381 |
| Dec 2024 | 0 | 1347559 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 11 May 2023 | Q1 2023 Earnings Call Transcript |
-
What's the price of Invivyd stock today?
One share of Invivyd stock can currently be purchased for approximately $0.57.
-
When is Invivyd's next earnings date?
Unfortunately, Invivyd's (IVVD) next earnings date is currently unknown.
-
Does Invivyd pay dividends?
No, Invivyd does not pay dividends.
-
How much money does Invivyd make?
Invivyd has a market capitalization of 52.40M. Invivyd made a loss 198.64M US dollars in net income (profit) last year or -$0.38 on an earnings per share basis.
-
What is Invivyd's stock symbol?
Invivyd, Inc. is traded on the NASDAQ under the ticker symbol "IVVD".
-
What is Invivyd's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Invivyd?
Shares of Invivyd can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Invivyd have?
As Jul 2024, Invivyd employs 94 workers, which is 12% more then previous quarter.
-
When Invivyd went public?
Invivyd, Inc. is publicly traded company for more then 4 years since IPO on 6 Aug 2021.
-
What is Invivyd's official website?
The official website for Invivyd is adagiotx.com.
-
Where are Invivyd's headquarters?
Invivyd is headquartered at 1601 Trapelo Road, Waltham, MA.
-
How can i contact Invivyd?
Invivyd's mailing address is 1601 Trapelo Road, Waltham, MA and company can be reached via phone at +7 818190080.
Invivyd company profile:
Invivyd, Inc.
adagiotx.comExchange:
NASDAQ
Full time employees:
94
Industry:
Biotechnology
Sector:
Healthcare
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.
1601 Trapelo Road
Waltham, MA 02451
Waltham, MA 02451
CIK: 0001832038
ISIN: US00534A1025
CUSIP: 00534A102
